置换杨图的组合性质及其应用

置换杨图本质上是A.Postnikov在研究完全非负Grassnann元胞及其元胞分解时所定义的]-图(]-diagram)的一个子集.它的发现引起许多组合学者的关注和研究,其中L.K.Williams和E.Steingrí-sson是最先关注这类组合结构的,他们在研究它的组合性质时发现了它与置换群之间存在着一一对应关系Ψ.从置换杨图本身的结构出发按照行递归的方式给出了Ψ是一一映射的一个新方法,利用这种方法可简单地将任意的一个排列π∈Sn分解成若干圈的乘积形式,并且每个圈中的元素都是按递减顺序排列.     

Linear codes associated to skew-symmetric determinantal varieties

In this article we consider linear codes coming from skew-symmetric determinantal varieties, which are defined by the vanishing of minors of a certain fixed size in the space of skew-symmetric matrices. In odd characteristic, the minimum distances of these codes are determined and a recursive formula for the weight of a general codeword in these codes is given.     

Carlsson's rank conjecture and a conjecture on square-zero upper triangular matrices

Let k be an algebraically closed field and A the polynomial algebra in r variables with coefficients in k. In case the characteristic of k is 2, Carlsson [9] conjectured that for any DG-A-module M of dimension N as a free A-module, if the homology of M is nontrivial and finite dimensional as a k-vector space, then $2^r\le N$. Here we state a stronger conjecture about varieties of square-zero upper triangular $N\times N$ matrices with entries in A. Using stratifications of these varieties via Borel orbits, we show that the stronger conjecture holds when $N<8$ or $r<3$ without any restriction on the characteristic of k. As a consequence, we obtain a new proof for many of the known cases of Carlsson's conjecture and give new results when $N>4$ and $r=2$.     

一类精细化Eulerian多项式的若干性质

最近,孙华定义了一类新的精细化Eulerian多项式,即$$A_n(p,q)=\sum_{\pi\in \mathfrak{S}_n}p^{{\rm odes}(\pi)}q^{{\rm edes}(\pi)},\ \ n\ge 1,$$ 其中$S_n$表示$\{1,2,\ldots,n\}$上全体$n$阶排列的集合, odes$(\pi)$与edes$(\pi)$分别表示$S_n$中排列$\pi$的奇数位与偶数位上降位数的个数.本文利用经典的Eulerian多项式$A_n(q)$ 与Catalan 序列的生成函数$C(q)$,得到精细化Eulerian 多项式$A_n(p,q)$的指数型生成函数及$A_n(p,q)$的显示表达式.在一些特殊情形,本文建立了$A_n(p,q)$与$A_n(0,q)$或$A_n(p,0)$之间的联系,并利用Eulerian数表示多项式$A_n(0,q)$的系数.特别地,这些联系揭示了Euler数$E_n$与Eulerian数$A_{n,k}$之间的一种新的关系.     

Norms and lower bounds of some matrix operators on Fibonacci weighted difference sequence space

Norm of an operator T:X→Y is the best possible value of U satisfying the inequality and lower bound for T is the value of L satisfying the inequality where ‖.‖_X and ‖.‖_Y are the norms on the spaces X and Y, respectively. The main goal of this paper is to compute norms and lower bounds for some matrix operators from the weighted sequence space ?_p(w) into a new space called as Fibonacci weighted difference sequence space. For this purpose, we firstly introduce the Fibonacci difference matrix and the space consisting of sequences whose ‐transforms are in .     

An optimal perturbation bound

Cai and Zhang establish separate perturbation bounds for distances with spectral and Frobenius norms (Cai T, Zhang A. Rate‐optimal perturbation bounds for singular subspaces with applications to high‐dimensional statistics. The Annals of Statistics. 2018; Vol. 46, No. 1: 60?89). We extend their theorem to each unitarily invariant norm. It turns out that our estimation is optimal as well.     

Simultaneous quantification of ondansetron and tariquidar in rat and human plasma using a high performance liquid chromatography‐ultraviolet method

Ondansetron, a widely used antiemetic agent, is a P‐glycoprotein (P‐gp) substrate and therefore expression of P‐gp at the blood–brain barrier limits its distribution to the central nervous system (CNS), which was observed to be reversed by coadministration with P‐gp inhibitors. Tariquidar is a potent and selective third‐generation P‐gp inhibitor, and coadministration with ondansetron has shown improved ondansetron distribution to the CNS. There is currently no reported bioanalytical method for simultaneously quantifying ondansetron with a third‐generation P‐gp inhibitor. Therefore, we aimed to develop and validate a method for ondansetron and tariquidar in rat and human plasma samples. A full validation was performed for both ondansetron and tariquidar, and sample stability was tested under various storage conditions. To demonstrate its utility, the method was applied to a preclinical pharmacokinetic study following coadministration of ondansetron and tariquidar in rats. The presented method will be valuable in pharmacokinetic studies of ondansetron and tariquidar in which simultaneous determination may be required. In addition, this is the first report of a bioanalytical method validated for quantification of tariquidar in plasma samples.